A “block-and-replace” regimen of corticosteroid therapy can be used to manage COVID-19 in people with Cushing’s disease, a new…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with Cushing’s disease have a high risk of being deficient in vitamin D, but taking supplements can improve…
Corcept Therapeutics is on track to ask the U.S. Food and Drug Administration (FDA) to approve the investigational therapy relacorilant…
Xeris Pharmaceuticals has selected the specialty pharmacy PANTHERx Rare to distribute Recorlev (levoketoconazole), the company’s therapy that was recently…
Sparrow Pharmaceuticals is gearing up for the start of a Phase 2 trial that will assess the safety and…
In people with Cushing’s disease, the activity of an enzyme that breaks down vitamin D is altered, which may…
The desmopressin stimulation test can be useful to diagnose Cushing’s during pregnancy, a time when its identification may be particularly challenging…
At an upcoming conference offered by the University of Pennsylvania (Penn), experts will share the latest approaches and techniques for…
A newly discovered mutation in a gene called USP8 may contribute to the development of pituitary tumors, which are the underlying…
Analyzing small amounts of tumor DNA that end up in the bloodstream could be useful for assessing the course of…